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RUNNING HEAD
Computational models provide insight into asthma
SUBJECT CATEGORY
8.21 Modelling: Structure Function Relationships
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4ABSTRACT
RATIONALE: Asthma is characterised by disease within the small airways. Several studies 
have suggested that forced oscillation technique derived resistance at 5Hz minus 20Hz (R5-R20) 
is measure of small airways disease, however there has been limited validation of this 
measurement to date. 
METHODS:  Patient based complete conducting airway models were generated from CT scans 
to simulate the impact of different degrees of airway narrowing at different levels of the airway 
tree on forced oscillation R5-R20 (n=31). The computational models were coupled with 
regression models in an asthmatic cohort (n=177), to simulate the impact of small airway 
narrowing on asthma control and quality of life. The computational models were used to predict 
the impact on small airway narrowing of type-2 targeting biologics using pooled data from two 
similarly design randomised placebo control biologic trials (n=137).
RESULTS: Simulations demonstrated that narrowing of the small airways had a greater impact 
on R5-R20 than narrowing of the larger airways and was associated (above a threshold of 
approximately 40% narrowing) with marked deterioration in both asthma control and asthma 
quality of life, above the minimal clinical important difference. The observed treatment effect on 
R5-R20 in the pooled trials equated to a predicted small airway narrowing reversal of 
approximately 40%.
CONCLUSIONS: We have demonstrated using computational modelling that forced oscillation 
R5-R20 is a direct measure of anatomical narrowing in the small airways, that small airway 
narrowing has a marked impact on both asthma control and quality of life and may be modified 
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5by biologics. 
WORD COUNT: 248
KEY WORDS: Asthma, Forced Oscillation Technique, Small Airways, Imaging, 
Computational Modelling, Integrative Modelling.
CLINICAL IMPLICATIONS
FOT measured low-high frequency resistive difference (R5-R20) was found to be a sensitive and 
clinically valuable marker of small airways disease.
CAPSULE SUMMARY
Coupling of computational airway models with statistical models has demonstrated that the 
forced oscillation measure R5-R20, is a sensitive to anatomical small airways disease and the 
models predict that narrowing of the small airways is associated with worsening asthma control 
and quality of life and may be modified by biologics.
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6ABBREVIATIONS
ACQ: Asthma control questionnaire
AQLQ: Asthma quality of life questionnaire
CT: Computed tomography
FOT: Forced oscillation technique
FRC: Functional residual capacity
GINA: Global initiative for asthma
IOS: Impulse Oscillometry
LLN: Lower limit of normal
MRI: Magnetic resonance imaging 
PET: Positron emission tomography
R5: Resistance at 5 Hz
R20: Resistance at 20 Hz
R5-R20: Resistance at 5 Hz minus resistance at 20 Hz
SD: Standardised residual
SO: Strahler order
TLC: Total lung capacity
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7INTRODUCTION
Asthma is a complex chronic inflammatory disease that involves both central and small airways 
(1-2). Multiple lines of evidence suggest that within asthmatics, the small airways are 
dysfunctional (3), inflamed (4) and damaged (5). Several in vivo imaging approaches have been 
utilised to study the small airways, including hyperpolarised gas, magnetic resonance imaging 
(MRI), and computed tomography (CT) imaging (6-7). These studies have demonstrated that 
spatial disease in the small airways captured by both MRI and CT of the lungs may be 
adequately reflected in more simple measures of small airways disease using the forced 
oscillation technique (FOT).
FOT is a simple technique that perturbs the respiratory system during tidal breathing, by using a 
series of pressure oscillations, over a range of frequencies (typically 5-35Hz), applied at the 
mouth. Due to the lack of a required breathing manoeuvre, the FOT can be easily deployed 
across age groups, from young children, to the elderly. This suggests that it may be a suitable and 
clinically applicable tool for the measurement of small airways disease in adults and children 
with asthma (8). The change in resistance from low to high frequency ranges (e.g. resistance at 
5Hz minus 20Hz; R5-R20), is often suggested as a putative marker of small airways obstruction 
and has been shown to predict loss of asthma control in children (9). This measure has also been 
shown to correlate with measures of small airway inflammation (10), exacerbations (11), and 
response to inhaled corticosteroids, including small particle formulations in adult asthma (12-14). 
Recently, a multinational study of small airways dysfunction markers in adult asthma identified 
that IOS-measured R5-R20 was the most strongly correlated marker of small airways disease, of 
several small airway physiological markers. Furthermore 42% of the adult asthma population 
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8demonstrated an abnormal R5-R20 measurement. These observations provide strong evidence 
that FOT derived R5-R20 is a useful clinical tool to identify small airways disease (15).
However, despite these observational studies the precise association between small airway 
anatomical narrowing and R5-R20 is poorly understood. Furthermore, the impact of small airway 
narrowing on asthma control, and quality of life has yet to be established. 
Within this study, we hypothesised that: (i) anatomical disease within small airways (≤ 2mm in 
diameter) is a critical determinant of forced oscillation derived R5-R20  whilst accounting for 
relevant confounders and that R5-R20  and that (ii) anatomical narrowing of the small airways 
would be predicted to have a significant impact on both asthma control and quality of life.(iii)  
We also attempted to predict the impact of anti-inflammatory biologics targeting type 2 
inflammation on small airway narrowing.
To investigate these hypotheses, we collected and analysed data from a variety of different 
sources. Our approach utilises patient-based computational modelling of the FOT (16); and 
statistical regression models that link R5-R20 to asthma control and quality of life. Finally post 
hoc evaluation of existing placebo controlled clinical trial data was used to estimate the likely 
impact of anti-inflammatory biologics on small airway narrowing. The overarching concept of 
the study is outlined visually in Figure 1. 
Some of the results of these studies have been previously reported in the form of an abstract(17).
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9METHODS
Results within this study were created through combined analysis of three separate data sources: 
(i) a large asthmatic cohort, (ii) a smaller computational modelling cohort, and (ii) pooled 
clinical trial cohorts. 
(i) Bio-statistical modelling cohort
An adult asthmatic cohort (n=177), was recruited from Glenfield Hospital, in Leicester, UK. 
Current smokers, and patients with a history of ≥ 10 pack years were excluded. Asthma was 
diagnosed by a physician, according to current British Thoracic Society guidelines (18), with 
severity defined according to the Global Initiative for Asthma (GINA) treatment intensity steps 
(19). Details of the clinical study protocol are outlined in the online supplement, but in brief, 
participants attended for up to two visits, and underwent: Evaluation with asthma questionnaires 
for control and quality of life (ACQ-6 and AQLQ), and exacerbation frequency (20-21); post 
bronchodilator impulse oscillometry (IOS), using a Jaeger MasterScreen (22); and spirometry, 
according to European Respiratory Society (ERS) standards (23).
The study protocol for the recruitment and assessments in the two studies above was approved 
by the National Research Ethics Committee – East Midlands Leicester (approval number 
08/H0406/189] and all subjects gave their written informed consent.
The data collected from this cohort was used to create a statistical regression linking R5-R20 to 
ACQ, and AQLQ. The linear regression was calculated using a stepwise algorithm, and 
incorporated GINA treatment intensity, age, sex, smoking exposure in pack years and spirometry 
measured forced-vital capacity (FVC) and forced expiratory volume/forced vital capacity ratio 
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(FEV1/FVC) as potential confounding variables.  Discriminatory variables were retained by the 
stepwise regression model and include as independent predictors as a means of adjustment.
 (ii) Computational modelling cohort
A subset of 20 of the 177 asthmatic adults [ (9 female, 11 male), who consented to participate in 
a CT imaging sub-study were selected at random from the cohort of 177 patients, and 11 healthy 
controls were recruited for imaging. Full details of the CT protocol are outlined in the original 
study (15).  All imaging was performed post-bronchodilator. Clinical characteristics of this cohort 
were well matched to the controls within the cohort and similar to patients with preserved 
spirometry in the overall cohort (Table 1 supplementary material) and well matched to the 11 
control subjects.  GINA treatment step 3[3: 4] and R5-R20 0.03[0.01:0.11] Kpa.s.L-1], age 
59[47:65] years alongside 11 age matched healthy volunteers (6 female, 5 male), R5-R20 0.03 
[0.02:0.06] Kpa.s.L-1) and age 59[43:66] years. Healthy subjects had no prior history of 
respiratory disease, normal spirometry and < 10 pack years smoking history. 
- Creation of patient-based airway models
From each of the 31 inspiratory CT scans, a patient-based virtual airway structure was derived, 
by extracting centrelines of the central airways (to generation 6-10) and using a recursive 
algorithm (24) to grow the remainder of the conducting zone (to an average generation 16), within 
the identified lobar boundaries. The branch radii were scaled from total lung capacity (TLC) 
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down to functional residual capacity (FRC) using Lambert’s data (25). Each patient-based virtual 
lung consisted of 30,000-100,000 branches, with the entire set being originally presented by 
Bordas et al.(16). Within the original study, details of the structures were compared to histological 
data, with key features (radii, branch-lengths, etc.) lying within physiologically reasonable 
bounds(16). 
- Computational model of the forced oscillation technique
The FOT was simulated using an electrical-circuit analogous model (26), with full details 
presented in the online supplement. In short, impedance of each airway branch was 
approximated using the wave-equation (27). Total lung impedance was calculated by summing 
branch impedances in series and parallel, with each terminal bronchiole being subtended by a 
viscoelastic acinar model. This impedance was then added in series to contributions from the 
chest wall, trachea and glottis, and in parallel to contributions from cheek and upper airway 
shunting, all of which were parameterised using experimental data from the literature (28,29). All 
simulations were performed in MATLAB. 
Alongside simulating resistance in all patient-based structures, simulations were also performed 
in one of the structures derived from a healthy control, after application of artificial airway 
constrictions. Constrictions were applied by reducing branch radii in the structure by a fixed 
percentage (homogeneous) or drawing the reduction percentage from a normal distribution with 
a fixed mean (heterogeneous). Constrictions were either applied to all branches of a given 
Strahler order (marker of depth, 1 = terminal bronchiole, 12 = trachea), or to the small airways 
(orders 1-6) or large airways (7-10). 
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(iii) Clinical trial populations
To provide information on therapeutic intervention, we identified two similarly designed three-
month duration anti-inflammatory randomised double-blind placebo-controlled phase II trials, in 
moderate-severe uncontrolled asthma. Both trials have been previously reported (30,31), and 
evaluated known targets relevant to asthma pathology in the small airways (IL-13 (n= 76) and 
the CRTH2 receptor DP2 (n=61)) with systemic therapies that would be expected to engage with 
their target in the small airways 
Both trials used FOT-measured R5-R20 as an exploratory outcome, alongside ACQ, as an 
asthma control measure. Total cohort size (n=137) was chosen to provide 90% power for 
identification of a clinically meaningful change in R5-R20  of 0.03 kPa.s.L-1 (12-14, 32-34), with 
details given in the online supplement.  
Combined analysis procedure for model integration
The procedure for systematically and jointly analysing the various data sources is as follows. 
Resistance was simulated on each patient-based structure and compared against clinical 
measurements for validation. Then, model simulations were used to analyse the response of R5-
R20 to small and large airway constrictions. These results were compared to clinical 
stratifications seen in the larger asthmatic cohort. A regression model, derived from the larger 
cohort, was used to link R5-R20 to ACQ and AQLQ, allowing for improved result 
interpretability. The combined model was then used to link biologic therapy results to changes in 
small airway narrowing and asthma control. 
Statistical analysis
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Statistical analysis was performed using SAS 9.4, Prism 7, and MATLAB. A p-value of <0.05 was 
taken as the threshold for statistical significance. Comparisons across groups were performed using 
one-way ANOVA for parametric data or Kruskal–Wallis test for nonparametric data, and Fisher's 
exact test or the chi-squared test for proportions. Bonferroni/Dunn corrections for multiple 
comparisons were used as appropriate. Correlations between continuous variables were calculated 
using Pearson's correlation coefficient (R). We considered that FOT parameters were abnormally 
elevated when above 100% predicted of 95th percentile predicted value from the KORA cohort (35).
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RESULTS
Identification of small airways within the patient-based lung structures
Airway depth within the patient-based lung structures was annotated using Strahler order (SO - 
the number of branches from a given location to the nearest terminal bronchiole), a standardized 
method for describing branching networks (16). SO 1 refers to the terminal bronchioles, and on 
average, SO 12 to the trachea. Across the set of 31 structures the mean (std) airway diameter at 
SO 7 was 2.12mm (0.28 mm2), and at SO 6 was 1.39mm (0.21mm2), meaning orders 1-6 are treated 
as the small airways, and orders 7 and up as the large airways.  
Correlation of simulated and clinical resistance measurements. 
Within Figure 2a-b, we compare simulated (without artificial airway constriction) and clinically 
measured R5 and R20, across the 31 subjects who underwent CT imaging. As the figure shows, 
there is a moderate correlation [R2 (R5 = 0.35, p 0.05); R2 (R20 = 0.27, p 0.05)] between < <
simulated and clinical data, with only one significant outlier. The correlation of simulated and 
clinically measured R5-R20 was modest, and individual R5 and R20 correlation errors were 
additive (data now shown).
Sensitivity of R5-R20 to small airways constriction
Within Figure 2c-f, we illustrate the simulated response of R5-R20 to various types of artificial 
airway constrictions applied to a structure based off a healthy control. Panels 2c-d illustrate how 
R5-R20 responds to constriction, in both the presence and absence of heterogeneity (as defined in 
methods). In both cases R5-R20 responds sensitively to mild constriction, with the response being 
amplified as constriction increases. Significantly, a larger response is seen when constricting small 
airways (SO 1-6) than large airways. Additional simulations confirmed that 5Hz-20Hz was the 
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optimal difference for detection of small airways disease, though 5Hz-25Hz was similarly effective 
(Figure OS.3).
The response to small airway constriction is also illustrated in panels 2e-f. As shown, constriction 
of the small airways consistently produced larger responses than constriction of the large airways, 
regardless of whether constrictions were homogeneous or heterogeneous. Taking care to note the 
different axis scales used for R5 and R5-R20, the results clearly illustrate a larger relative increase 
in R5-R20 when comparing large and small airway constriction, than in R5.  These conclusions 
were the same when using other types of constriction distributions (online supplement). 
To further illustrate this sensitivity, within Figure 3 we show the relative contribution of the small 
airways, large airways, and cheek shunting, to R5 and R20, at baseline, and under mild (20%) and 
severe (50%) constriction, imposed uniformly on the small airways. In all three cases, R5 was 
dominated by small airway contributions more than R20. Furthermore, in the presence of severe 
airway constriction, the model derived R5-R20 (0.08 kPa.s.L-1) was similar to the median reported 
R5-R20 for asthmatics in our cross-sectional cohort (0.09 kPa.s.L-1, table OS.1), suggesting that 
the models are generating physiologically relevant values. 
Large asthmatic cohort stratification based on R5-R20
Within Figure 4, we evaluate the prevalence of small airways dysfunction in the large asthmatic 
cohort, measured using R5-R20, and compared to spirometric values. The cohort was broken into 
three sub-groups, based upon (i) a low forced vital capacity < the lower limit f normal (LLN)(32), 
(ii)  an abnormal FEV1/FVC < LLN, and (ii) normal spirometry (both FEV1≥ LLN and FVC≥ 
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LLN) outputs. (clinical interpretation and statistical summaries of the data underlying Figure 4 
are provided in the online supplementary materials).
Associating R5-R20 and small airway narrowing with patient outcomes
To allow for contextualization of R5-R20 in terms of reported patient outcomes, a linear regression 
model was built from the large asthmatic cohort data, to allow for prediction of asthma control 
(ACQ-6), and quality of life (AQLQ), based on patient R5-R20. This was done using a series of 
potential confounding independent variables (age, sex, GINA treatment intensity, FVC, 
FEV1/FVC, and smoking exposure in pack-years). Details of the regression model are summarized 
in the Table 1. 
Within Figure 5, we illustrate the potential value of the regression model, by transforming the R5-
R20 values in Figure 2e-f, to ACQ and AQLQ values, using a 95% confidence interval on the 
regression coefficients for R5-R20. These results illustrate that deterioration in asthma control and 
quality of life occurs much more rapidly under constriction of the small airways than the large 
airways. Starting from a mild constricted state (20% constriction), small increases to constriction 
(moving from 20% to 40% constriction) would be expected to yield clinically relevant changes (> 
0.5 units) in both ACQ and AQLQ.
 Linking small airway changes to treatment outcomes
Having established that R5-R20 is sensitive to small airways disease, and contextualizing this in 
terms of patient related outcome measures, we seek to further evaluate these results in the context 
of clinical trial measured treatment outcomes. As shown in Table 2, the pooled treatment effect 
[95% CI] of two anti-inflammatory therapies (30-31) on R5-R20 was -0.038kPa.s.L-1 [-0.05:-0.03, p 
< 0.0001], comparative to placebo. Based on the results in Figures 2-3, we estimate that this 
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treatment effect would be equivalent to a 35% [20-50%] reduction in small airway constriction, in 
the presence of moderate small airways dysfunction. 
Within Table 2, we present the pooled estimate of treatment effect on ACQ (approximate only, as 
the two studies used different ACQ variants), as -0.19 (-0.26:-0.11, p<0.0001). We note that the 
predicted change in ACQ (from our model) based on the illustrated change in R5-R20 would be   
-0.08 (-0.03:-0.19), which is consistent with the actual change. This is particularly noteworthy 
given the regression model was derived from a cohort independent of the clinical trials.
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DISCUSSION
Within this study, we have used a combination of computational modelling on patient-based lung 
structures to identify that low-high frequency resistive difference (R5-R20) is a clear marker of 
small airways anatomical constriction, and is strongly associated with patient outcome measures 
ACQ and AQLQ. Furthermore using our models, we have demonstrated that narrowing above a 
threshold of 40% in the small airways generates clinical important changes in asthma control and 
quality of life and that this effect is equivalent to the predicted narrowing reversal that would be 
expected with anti-inflammatory biologics based upon the observed treatment effects on R5-R20.
The validation of the computational lung impedance model, presented in Figure 2a-b, provides 
the largest (to our knowledge) patient-based validation of this model seen to date within the 
literature. The model that we have used has been used for large varieties of investigations within 
the literature (26,28,37,38). Given this, this study helps provide validation to many prior results, built 
upon the theoretical foundations of the model.
Our results add further credence to the mounting evidence supporting R5-R20 as a robust small 
airways detection tool. The recent multinational ATLANTIS trial identified that R5-R20 was one 
of the key physiological determinants of small airways disease in asthma (15). Furthermore, a recent 
study in COPD has linked anatomical narrowing of airways generations 7-9 measured with 
bronchoscopic optical coherence tomography with R5-R20 (39). Taken together our observations 
provide further evidence supporting the validity of the claim that R5-R20 is a physiological marker 
of small airways disease.
The results within this manuscript used 5Hz and 20Hz as the low and high frequency points for 
calculating resistive difference. This choice was made primarily due to the prevalence of R5-R20 
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within the literature, comparative to other index choices. However, for completeness, within the 
online supplement we also present a brief analysis of a variety of choices of low and high points 
within the frequency range 5-35Hz. Through this analysis it is shown that R5-R20 is significantly 
more sensitive to small airways constriction than most other frequency choices. 
The results in Figures 2-3 clearly illustrate the value of low-high frequency resistive difference as 
a marker of small airways dysfunction. This conclusion is furthered by the results in Figure 4, 
which suggest that R5-R20 may stratify small airways disease, even in the presence of normal 
spirometric values. This compares well to other results in the literature (3,15,40) which have 
suggested the value of R5-R20 as a predictor of small airways dysfunction. 
The analysis in Figures 2-4 becomes more meaningful when interpreted in context of the 
underlying statistical relationship between R5-R20, ACQ, and AQLQ, as in Figure 5. This figure 
illustrates that small airways constriction leads to significantly larger reductions in asthma control 
and quality of life, than large airway constrictions, suggesting that a major determinant of asthma 
control and quality of life may be disease within the small airways in keeping with the results of 
the multinational ATLANTIS study (15). The results in Figure 5 suggest that the initial effect of 
small airway constriction on ACQ and AQLQ is quite minimal, with an approximate 40% 
reduction in small airway radii needed to create the minimal clinically important change (0.5 
units). However, once disease is already present, smaller increases in disease severity appear to 
lead to much larger degradations in patient quality of life (e.g. moving from 50% to 60% 
constriction decreases AQLQ from approximately 5 to 3.5). 
The ability to more precisely connect morphological changes in lung structure with clinical 
pulmonary measurements, and patient quality of life assessments is a truly valuable and novel 
contribution. This is further illustrated by connecting these results to the clinical trial results in 
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Table 2. The pooled estimate effect on R5-R20 had a 95% confidence interval of -0.05:-0.03 
kPa.s.L-1. Interpreting this in terms of Figure 2e-f, allows for an approximate interpretation of this 
change in context of the underlying small airway morphology. Reductions in R5-R20 of this 
magnitude could be interpreted as being driven by a 35% [20:50%] reduction in mean constriction 
severity of the small airways (a transition from mild/severe constriction towards a healthy state). 
Importantly, the statistical regression relationship was also able to accurately predict the observed 
treatment effect on ACQ, from the observed effect on R5-R20, giving further confidence to the 
results. 
Study limitations
The concordance between simulated and clinically measured R5-R20 in our study was modest but 
illustrates the ability of the model to distinguish between high and low responses. Part of the error 
between simulated and clinical values may be due to the use of mean population data for the 
shunting and tracheal impedances, and the use of a simple constant-phase model (26), for respiratory 
zone contributions. 
Within recent work by this group (17), CT voxel deformation data was used to improve structural 
accuracy of the virtual lungs. For a subset of the virtual lungs in this study, this process improved 
the R2 between simulated and clinical R5 from 0.61 to 0.78. This suggests that a significant degree 
of noise in the model, may simply be due to limitations in imaging accuracy.
It should be noted that the computationalmodelling cohort was comprised of a randomly selected 
subset of the larger clinical cohort. This subset had R5-R20 values that spanned the range of the 
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larger cohort, and due to the randomized selection process, we do not believe that this subset biases 
the results. 
Finally, the simulated results in this manuscript relied on enforcing constricting patterns either 
homogeneously or through a normal distribution. For completeness, within the online 
supplement, we investigate the effect of skew-normally distributed airway constrictions on R5-
R20, showing qualitatively similar results to those contained within the main manuscript. 
SUMMARY
These findings illustrate a clear and consistent relationship between anatomical small airways 
disease, and lung impedance measurement R5-R20. Using a combination of patient-based 
computational modelling, large scale clinical assessment, and clinical trial data, this relationship 
can be linked to patient outcome measures, and be used to predict therapeutic intervention 
responses. Furthermore, this study stands as a prototype for the value of integrated computational-
clinical approaches to understand the role of small airways disease in respiratory medicine.
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FIGURE LEGENDS 
Figure 1: Diagram of the integrated modelling approach.
Legend to figure 1: The diagram shows many of the different clinical, statistical, and computational 
components that are used together in this integrated study. This includes the patient subset that underwent 
CT scans, leading to the creation of patient-based lung structures, and personalised FOT modelling; as 
well as the larger asthmatic cohort used to create regressive links between FOT outcomes, and more 
standardised asthmatic assessments. This integrative approach leads to a deeper understanding of the links 
between underlying physiology and patient outcomes. 
Figure 2: Analysis of the response of simulated R5-R20 to airways constriction.
Legend to figure 2: The ability of the model to simulate healthy (black circles) and asthmatic (red 
squares) patient values is first shown, with R2 values for (A) R5: 0.35, and (B) R20: 0.27, and strong 
statistical significance (p < 0.05) in both cases. In panels (C) and (D), the response of R5-R20 to 
homogeneous and heterogeneous constrictions at different depths (denoted by Strahler order) is given. In 
both cases, R5-R20 is seen to peak when constricting smaller airways (orders 1-6), and then decrease 
under upper airway constriction. The response of R5-R20 to small airways constriction is further 
illustrated by comparing homogeneous (E) and heterogeneous (F) constriction of all small airways (orders 
1-6) and central airways (orders 7-12). A consistently stronger response is seen from the small airways. In 
panels (E) and (F) R5 (right axis) and R5-R20 (left axis) are both given, with R5 showing a larger 
response, but a smaller distinction (particularly comparative to baseline values) between small and central 
airway constriction. 
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Figure 3: Relative contributions of small airways, central airways and upper airway/cheek 
shunting to R5 and R20.
Legend to figure 3: The simulated relative contributions are shown for a healthy subject, under mild 
constriction (20%), and severe constriction (50%) of all small airways, alongside the resistance and 
reactance curves from 2-35Hz. In all 3 cases, small airways contribute more significantly to R5 than R20, 
with the magnitude of this effect increasing with disease severity. This suggests that R5-R20 responds 
most strongly to small airways constriction. 
Figure 4: Stratification of the clinical study population according to FVC Z score and 
FEV1/FVC LLN.
Legend to figure 4: Stratification according to spirometry culminated in three different groups: gas 
trapping, Asthma/COPD overlap, early small airway disease. Pie charts show the percentage of patients in 
each group with R5-R20> 100% predicted, utilizing the 95th percentile KORA cohort quantile-quantile 
regression equations (Pie charts: white part corresponds to R5-R20>100% predicted and white part 
corresponds to R5-R20≤ 100% predicted). Further clinical details for each group can be found in the 
online supplement, Table OS.1.
Figure 5: Simulated response of ACQ and AQLQ to airways constriction.
Legend to Figure 5: The translation of the response of R5-R20 to small and central airways constriction, 
into ACQ and AQLQ, using regressive models from Table 1. Results were calculated using the mean 
regression parameter value for R5-R20 (black line), as well as the 95% confidence interval (coloured 
bands). For both ACQ and AQLQ, a much more severe response is seen under small airways constriction 
than central airways constriction, even after accounting for the uncertainty of the regression.
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TABLES
Table 1: Regression models for ACQ and AQLQ.
AQLQ Model
Effect Estimate Standard 
Error
P-value 95% CI Lower 
Bound
 95% CI Upper 
Bound
Intercept 5.832 0.445 < 0.001 4.953 6.712
R5-R20 
(kPa.s.L-1)
-3.292 0.967 0.001 -5.202 -1.383
GINA (1-5) -0.258 0.069 < 0.001 -0.394 -0.122
FVC (L) 0.199 0.090 0.028 0.021 0.377
ACQ-6 Model
Effect Estimate Standard 
Error
P-value 95% CI Lower 
Bound
95% CI Upper 
Bound
Intercept 1.911 0.715 0.008 0.499 3.322
R5-R20 
(kPa.s.L-1)
2.195 0.787 0.006 0.640 3.749
GINA (1-5) 0.314 0.058 <0.001 0.199 0.429
Age (yrs) -0.016 0.005 0.003 -0.027 -0.006
Pack-years 
(yrs)
0.018 0.008 0.033 0.001 0.034
Sex (Male) 0.378 0.145 0.01 0.091 0.665
FEV1/FVC -0.016 0.007 0.026 -0.030 -0.002
Legend: Results of stepwise (forward selection) linear regression models. Dependent variables are 
AQLQ and ACQ. For AQLQ independent variables are R5-R20, GINA treatment step, and forced vital 
capacity (FVC). For ACQ model independent variables are R5-R20, GINA treatment step, age, pack-
years (PYRS), sex, and FEV1/FVC. 
Page 30 of 54 AJRCCM Articles in Press. Published on 18-May-2019 as 10.1164/rccm.201812-2322OC 
 Copyright © 2019 by the American Thoracic Society 
31
Table 2: Pooled clinical trial data using R5-R20, and ACQ as markers.
Change from baseline to week 12 Treatment effect
Tralokinumab
(n = 36)
Placebo
(n = 40)
Change in ACQ-6 -0.96(0.14)¥ -0.87(0.14)¥ -0.08(0.20)§
p=0.67
Change in R5-R20
(kPa.s.L-1)
-0.04 (0.02)¥ -0.01 (0.01)¥ -0.03 (0.02)§
p = 0.19
Fevipiprant
(n = 29)
Placebo
(n = 32)
Change in ACQ-7 -0.18(0.92)¥ 0.14(0.96)¥ -0.32(0.24)§
p=0.19
Change in R5-R20
(kPa.s.L-1)
-0.03 (0.11)¥ 0.02 (0.11)¥ -0.05 (0.03)§
p = 0.11
Pooled
Pooled estimate change 
in ACQ
-0.612(0.62)¥ -0.42(0.64)¥ -0.19(0.21)§
p<0.0001
95% CI: -0.26 to -0.11
Pooled estimate change 
in R5-R20 (kPa.s.L-1)
-0.034 (0.07)¥ 0.002 (0.07)¥ -0.038 (0.024)§
p <0.0001
95% CI: -0.05 to -0.03
Legend for Table 1: ¥=mean (standard deviation), §=difference in means (standard error). Change and 
treatment effect on R5-R20 (Resistance at 5 HZ minus resistance at 20 Hz), and asthma control 
questionnaire (ACQ) of two three-month duration, anti-inflammatory, randomised double blind placebo 
controlled phase 2 trials in moderate-severe uncontrolled asthma, for both intervention and placebo (20-
21). Pooled estimated treatment effect [95% CI] of the two anti-inflammatory therapies is shown. Note 
that for ACQ, the two treatments used different validated variants of the questionnaire (ACQ6, and 
ACQ7). Given this, the pooled estimate treatment effect for ACQ is intended as approximate only. 
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 Figure 1: Diagram of the integrated modelling approach. 
The diagram shows many of the different clinical, statistical, and computational components that are used 
together in this integrated study. This includes the patient subset that underwent CT scans, leading to the 
creation of patient-based lung structures, and personalised FOT modelling; as well as the larger asthmatic 
cohort used to create regressive links between FOT outcomes, and more standardised asthmatic 
assessments. This integrative approach leads to a deeper understanding of the links between underlying 
physiology and patient outcomes. 
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 Figure 2: Analysis of the response of simulated R5-R20 to airways constriction. 
The ability of the model to simulate healthy (black circles) and asthmatic (red squares) patient values is first 
shown, with R2 values for (A) R5: 0.35, and (B) R20: 0.27, and strong statistical significance (p < 0.05) in 
both cases. In panels (C) and (D), the response of R5-R20 to homogeneous and heterogeneous constrictions 
at different depths (denoted by Strahler order) is given. In both cases, R5-R20 is seen to peak when 
constricting smaller airways (orders 1-6), and then decrease under upper airway constriction. The response 
of R5-R20 to small airways constriction is further illustrated by comparing homogeneous (E) and 
heterogeneous (F) constriction of all small airways (orders 1-6) and central airways (orders 7-12). A 
consistently stronger response is seen from the small airways. In panels (E) and (F) R5 (right axis) and R5-
R20 (left axis) are both given, with R5 showing a larger response, but a smaller distinction (particularly 
comparative to baseline values) between small and central airway constriction. 
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 Figure 3: Relative contributions of small airways, central airways and upper airway/cheek shunting to R5 
and R20. 
The simulated relative contributions are shown for a healthy subject, under mild constriction (20%), and 
severe constriction (50%) of all small airways, alongside the resistance and reactance curves from 2-35Hz. 
In all 3 cases, small airways contribute more significantly to R5 than R20, with the magnitude of this effect 
increasing with disease severity. This suggests that R5-R20 responds most strongly to small airways 
constriction. 
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 Figure 4: Stratification of the clinical study population according to FVC Z score and FEV1/FVC LLN. 
Stratification according to spirometry culminated in three different groups: gas trapping, Asthma/COPD 
overlap, early small airway disease. Pie charts show the percentage of patients in each group with R5-R20> 
100% predicted, utilizing the 95th percentile KORA cohort quantile-quantile regression equations (Pie 
charts: white part corresponds to R5-R20>100% predicted and white part corresponds to R5-R20≤ 100% 
predicted). Further clinical details for each group can be found in the online supplement, Table OS.1. 
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 Figure 5: Simulated response of ACQ and AQLQ to airways constriction. 
The translation of the response of R5-R20 to small and central airways constriction, into ACQ and AQLQ, 
using regressive models from Table 1. Results were calculated using the mean regression parameter value 
for R5-R20 (black line), as well as the 95% confidence interval (coloured bands). For both ACQ and AQLQ, a 
much more severe response is seen under small airways constriction than central airways constriction, even 
after accounting for the uncertainty of the regression. 
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ONLINE SUPPLEMENT: Lung computational models and the role of the small airways in 
asthma
Supplement 1: Clinical study protocol
Within the main study, data analysis was performed on clinical measurements taken from an 
asthmatic cohort. For brevity, details of the clinical data collection were omitted in the 
manuscript, these details are presented here. 
A group of 177 asthmatic adults were recruited from Glenfield hospital, Leicester, UK. Current 
smokers, and patients with a history of  ≥ 10 pack years were excluded. All participants attended 
for up to two visits (within a week), not less than six weeks following an asthma exacerbation. 
Physiological tests and CT [at both total lung capacity (TLC) and functional residual capacity 
(FRC)] were performed 15 minutes after administration of the short-acting bronchodilator via 
Volumatic: 400μg. 
In addition to the collection of demographic and clinical details, six-point Juniper Asthma 
Control Questionnaire (ACQ-6) and standardised Asthma Quality of Life Questionnaire AQLQ 
[AQLQ(S)] (1-2) were completed. IOS was performed using a Jaeger MasterScreen (Viasys 
Healthcare GmbH, Hoechberg, Germany) (3) and spirometry, according to ATS/ERS                      
standards (4). 
IOS values are known to be associated with height, sex and age. Despite the lack of well-
established reference values for IOS parameters from a large and mixed adult population, efforts 
have been taken place to address this need (5). We utilised normative values appropriately 
adjusted for age, sex and height for IOS that have been developed in a large healthy Caucasian 
never smoking population of a similar median age to the asthma population in this study (6). We 
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considered that impulse oscillometry parameters were abnormally elevated when above 100% 
predicted of 95th percentile predicted value from the KORA cohort. 
For the therapeutic intervention cohorts, both studies used FOT-measured R5-R20 as an 
exploratory outcome, alongside ACQ as a measure of asthma control. We pooled the results of 
the trials as we estimated based upon previous anti-inflammatory inhaled steroid studies in 
asthma that to detect a 0.03 Kpa.s.L-1 change in R5-R20 (7-11), with a SD of 0.05 Kpa.s.L-1(12), we 
would require and n =58 patients per group (116 patients in total) to have a 90% power and an α: 
0.05.
Supplement 2. Outline of the computational lung impedance model
Within the study, we presented the results of simulations of lung impedance on a set of 1D 
structural representations of the lungs. For brevity full details of the model were omitted from the 
main manuscript, and are instead presented here. 
All of the virtual, patient-based conducting zone lung structures (created through CT segmentation, 
and algorithmic generation(13-15)), are 1D in nature. To simulate lung impedance on these 1D 
structures, we use an electrical circuit analogous model, which is widely used within the 
literature(16-17). This model assumes that each branch independently contributes to impedance, with 
total lung impedance being the additive result of series and parallel contributions from all branches 
in the network. 
To approximate the impedance Zj of a branch j, in response to a pressure pulse of frequency f, we 
use the model proposed by Benade(18) and Thurston(19):
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𝑍𝑗 =  (𝑖 𝜔𝜌𝑙𝑗𝜋𝑟2𝑗 )(1 ― 2𝑟𝑣 ―𝑖𝐽1(𝑟𝑣 ―𝑖)𝐽0(𝑟𝑣 ―𝑖)) ―1,         𝑟𝑣 =  (𝜔𝜌𝜇 )1/2𝑟𝑗 
where  is the air density, µ is the air viscosity,  is the angular frequency, lj and rj are the 𝜌 𝜔 = 2𝜋𝑓
branch length and radius, , and J0 and J1 are the zeroth and first solutions to Bessel’s 𝑖 =  ―1
equation. 
At the end of each terminal bronchiole, a constant-phase viscoelastic model was used to account 
for acinar contributions to impedance (17) such that the impedance of each acinar region (Zacin) is 
given by
𝑍𝑎𝑐𝑖𝑛 =  𝐺 ― 𝑖𝐻𝑁 𝜔𝛼 ,
where G and H are coefficients for tissue damping and elastance respectively, N is the total number 
of terminal bronchioles in the structure, and
𝛼 =  2𝜋𝑡𝑎𝑛 ―1(𝐻𝐺).
The parameters G and H were taken from standard values in the literature (20) as 0.12 and 0.57 
kPa.L-1 respectively. 
The total impedance of the branch structure was calculated by summing up the impedances of each 
branch and acinar region in series and parallel, analogous to an electrical circuit. Alongside the 
total airway tree impedance, chest wall, tracheal, and glottal resistances (taken as 0.049kPa.s.L-1), 
and chest wall elastance (taken as 1.04kPa.s.L-1) were added in series to the airway tree, 
parameterised from mean population clinical measurements(21). Finally, upper airway and cheek 
shunting were added in parallel to the rest of the model. The shunt data was taken from the 
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literature(22) , and interpolated using least-squares with the models  and 𝑅 =  𝑎/(𝑏 + 𝑓)
, where a, b, c, and d are the data-fitting parameters.𝑋 =  𝑐 𝑙𝑜𝑔(𝑓) +  𝑑
To aid interpretation, in Figure OS.1 we give a diagram of the key components of the 
computational model procedure. As shown in the figure, CT scans (A) are used to generate a 
virtual representation of the upper airways and algorithmic generation to generate the remainder 
of the conducting zone structure (B). Each branch in this structure is assumed to have an 
impedance Z, calculated by solving the wave equation in a cylindrical conduit. Total impedance 
of the airways is calculated by summation of branch impedances in parallel and series (C), with 
each branch being subtended by a constant-phase respiratory zone impedance. The conducting 
zone and respiratory zone impedance curves are added in series to tracheal and chest wall 
impedances, and in parallel to cheek shunting (D), to give total impedance. This leads to the 
simulation of resistance (E) and reactance (F) curves over the desired frequency range. 
Supplement 3 – Summaries and stratification of the asthmatic cohort
Figure 4 in the main manuscript presented a summary of analysis and stratification of the large 
asthmatic cohort, based on R5-R20 measurements, and spirometric measurements. Here we 
provide summary statistics, and analysis of the data. 
In Table OS.1 we present summary statistics of the clinical data from the asthmatic cohort. This 
data has been stratified according to spirometric values, specifically on their forced vital capacity 
(FVC) Z score, and whether FEV1/FVC is less than the lower limit of normality. Patients with 
abnormal FVC are shown in group 1 [FVC Z score < -1.64 (n=30)]; patients with normal FVC 
but abnormal FEV1/FVC in group 2 [FVC Z score ≥ -1.64 but FEV1/FVC < LLN (n=52)] and 
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patients with normal spirometry, in group 3 [FVC Z score ≥ -1.64 and FEV1/FVC ≥ LLN 
(n=95)], 11/95 patients within group 3 had evidence of ‘early small airways disease’ with an R5-
R20 > 100% predicted, as represented schematically on Figure 4 (main manuscript). 
Patients in group 1 have significantly poorer asthma outcomes, measured with ACQ-6 (p=0.002) 
and higher number of exacerbations (p<0.0001), compared with patients with normal spirometry 
and abnormal FEV1/FVC ratio alone. Additionally, this group presented significantly higher 
values for R5, R20 and R5-R20. The median R5-R20 was significantly lower in the early disease 
group compared to groups 1 and 2 (0.05 Kpa.s.L-1, p<0.0001). Nonetheless, as seen in Figure 4 
(main manuscript), 12% of patients in this group have isolated small airways disease, in the 
presence of normal spirometric indices. To analyse group 3 further (to help detect early signs of 
small airways disease) we split the group into two subsets, 3A: patients with a normal R5-R20; 
3B: patients with R5-R20 > 100% of predicted (11 cases in total). Within Figure OS.2 we 
compare spirometric and oscillometric responses of this group, indicating the occurrence of 
abnormal R5-R20 in the presence of normal spirometric measurements (A). Additionally, panels 
B, C and D population show asthma outcomes and exacerbations across the three groups. The 
number of exacerbations per year is significantly higher in the subset with abnormal R5-R20 
(p=0.036). Additionally ACQ-6 and AQLQ show a similar but non-significant trends for worst 
outcomes for subset 3B.
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Table OS.1: Clinical Characteristics of the asthma population
Group 1: 
(n = 30)
FVC Z score <     
- 1.64
Group 2: 
(n=52)
FEV1/FVC < 
LLN & FVC Z 
score≥-1.64
Group 3: 
(n=95)
FEV1/FVC≥ 
LLN & FVC Z 
score ≥ -1.64
Kruskal-
Wallis                 
p-value
Age (years) 60 (45-65) 58 (47-64) 56 (45-65) 0.734
Sex [% male (n)]b 53 (16) 54 (28) 40 (38) 0.250
BMI (kg/m2) 28 (24-34) 27 (23-30) 28 (25-32) 0.200
Smoking pack year 
history
0 (0-0)¥ 0 (0-4) 0 (0-2) 0.039
GINA treatment 
step (number per 
group: 1, 2-4, 5)b
2, 14, 14 4, 28, 20 11, 67, 17 0.007
ACQ-6 1.83 (0.77-3.07) 1.62 (0.83-2.79) 1.14 (0.58-
1.71)Δ,µ
0.002
AQLQ 5.19 (3.67-5.94) 5.62 (3.76-6.27) 5.67 (4.78-6.31) 0.052
Exacerbations  
(year prior to visit 
1)
3 (1-4) 1 (0-3) 1 (0-3) <0.0001
GLI-FEV1 Z score -2.82 (-3.37- -
2.27) Δ,¥
-1.91 (-2.46- -
1.26)
-0.43 (-1.02-
0.37)µ
<0.0001
R5 (kPa.s.L-1) 0.52 (0.42-0.63) 
Δ
0.48 (0.33-0.58) 0.39 (0.31-0.47) 
µ
<0.0001
R5 % predicted 
(95th percentile)
117 (96-162)Δ 105 (85-139) 88 (74-106)µ <0.0001
R20 (kPa.s.L-1) 0.35 (0.31-0.48) 0.35 (0.29-0.44) 0.33 (0.28-0.38) 0.061
R20 % predicted 
(95th percentile)
108 (91-135)Δ 103 (88-123) 91 (79-106)µ 0.0017
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Legend: R5-R20: Resistance at 5 Hz minus resistance at 20 Hz; LLN: Lower limit of normal; BMI: Body 
Mass Index; ACQ: Asthma control questionnaire; AQLQ: Asthma quality of life questionnaire; FEV1: 
Forced expiratory volume in one second; FVC: Forced vital capacity; Z-FEV1 = Global lung Initiative 
(GLI) Z score; R5-R20: Resistance at 5 Hz minus resistance at 20 Hz. Data expressed as median (Q1-Q3). 
b: χ2 test p value. Δ p<0.05 group 1 vs group 3; µ p<0.05 group 2 vs group 3; ¥ p<0.05 group 1 vs group 
2.
Supplement 4 – Comparison of resistive difference frequency points. 
The key hypothesis of this study is that low-high frequency resistive difference could be a 
valuable marker of small airways dysfunction in the human lungs. The definition of such a 
marker necessitates the choice of which frequency is ‘low’ and which is ‘high’. Due to their 
prevalence within the literature, we have chosen 5Hz and 20Hz as the low and high points 
respectively. However, for completeness, we briefly analyse the broader spectrum of potential 
markers within the 5-35Hz range. 
We first introduce the notation Rf, to denote the total lung resistance in response to a pressure 
frequency . The low-high resistive difference between two frequencies  and  is then: 𝑓 𝑓1 𝑓2 𝑅𝑓1
 ―𝑅𝑓2.
The best choice of low and high point is one which most significantly amplifies the resistive 
difference under small airways constriction, while minimising the response under central airways 
constriction. To identify this choice, we define the index: 
R5-R20 (kPa.s.L-1) 0.15 (0.07-
0.21)Δ
0.09 (0.04-0.18) 0.05 (0.03-0.09)µ <0.0001
R5-R20 % 
predicted (95th 
percentile)
100 (48-143)Δ 70 (25-116) 38 (23-66)µ <0.0001
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∆𝑅𝑓1𝑓2 =  1𝑅𝑓1([𝑅𝑓1 ― 𝑅𝑓2]𝑠𝑚𝑎𝑙𝑙 ― [𝑅𝑓1 ― 𝑅𝑓2]𝑐𝑒𝑛𝑡𝑟𝑎𝑙).
 Where subscripts ‘small’, and ‘central’ denote the marker response under 50% constriction of 
the small and central airways respectively (using the same constriction procedure as in Figure 
2e-f). This index is normalised by the baseline low resistance , to account for larger 𝑅𝑓1
frequency ranges naturally leading to larger resistive difference. 
In Figure OS.3 we illustrate the values of  for a range of choices of , and with ∆𝑅𝑓1𝑓2 𝑓1 𝑓2 = 𝑓1
. As can be seen, the largest values of  occur when Hz, and  +1, 𝑓1 +2, …, 35 ∆𝑅𝑓1𝑓2 𝑓1 = 5 𝑓2 =
20-25Hz. This suggests that the marker we have chosen (R5-R20) is particularly effective at 
isolating small airways dysfunction, comparative to most other choices. However, it also 
suggests that similar utility could be found in similar markers such as R5-R25. 
Supplement 5 – Analysis of skew-normally distributed airway constrictions
Within the main manuscript we presented a series of results which analysed the response of R5-
R20 to constriction of the small and central airways. These constrictions were applied either 
homogeneously (constricting each branch by the same amount) or heterogeneously, drawing 
each constriction from a normal distribution, with a fixed mean µ, and standard deviation 0.2 µ. 
While comparison of these two cases illustrated qualitatively similar response patterns, these are 
not the only potential ways that constrictions could be applied. 
In particularly, given the non-linear relationship between smooth muscle contraction and airway 
shortening, it could be argued that a skewed normal distribution is more representative of asthma 
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than a standard normal distribution. To investigate this, we first define the skew-normal 
distribution, through the probability density function (pdf):
𝑝𝑑𝑓(𝜇,𝜎,𝛼) =  2
2𝜋𝜎2𝑒 ―
(𝑥 ― 𝜇)22𝜎2 ∫
𝑥 ― 𝜇
𝜎 𝛼
―∞
1
2𝜋
𝑒 ― 𝑡
2/2𝑑𝑡
where  and  and the mean and standard deviation of the original normal distribution, and  is 𝜇 𝜎 𝛼
the degree of applied skew.
To illustrate the effect of the skewing, we recreate the results in Figure 2c-f, using the skew-
normal distribution. Constrictions were applied to either an entire Strahler order (1-12), all small 
airways (1-6) or all central airways (7-10). Like the original simulations, constrictions were 
applied using a mean constriction rate  ( ), with . The constrictions 𝜇 𝜇 = 0.05,…, 0.65 𝜎 = 0.2𝜇
were applied using either a strong leftward skew ( ), or rightward skew ( ). As with 𝛼 =  ― 4 𝛼 =  4
the original simulations, a constriction rate that exceed 95% was floored to this value to avoid 
non-physical scenarios. 
In Figure OS.4 we show the response of R5-R20 to both negative and positive skew-normally 
distributed constrictions. We note that while specific index values are different to those seen in 
Figure 2c-f, the overall trend is qualitatively the same. In both cases, the response of the index to 
small airways constriction is greater than the response to central airways constriction, with peak 
values occurring around constriction of Strahler order 6-7. 
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FIGURE LEGENDS
Figure OS.1: Diagram of the integrated FOT modelling approach. Patient specific CT scan 
data (A) is used to create patient-based virtual airway structures (1) (to generations 6-10), with 
the remainder of the small conducting airways being generated algorithmically (2) (B). These 
structures then have patient-specific impedances calculated through an electrical circuit 
analogous model (C), which is connected to global models for tracheal and chest wall 
contributions, and cheek shunting (D). This allows for the effective simulation of resistance (E) 
and reactance (F) curves across the desired frequency range. 
Figure OS.2: Population stratification and clinical outcomes in patients with normal 
spirometry. (A) Dot plot presenting study population according to spirometric outcomes (grey: 
spirometry strata with gas trapping, asthma/COPD overlap in figure 4: main manuscript). (B-D) 
Data presented for patients in the normal spirometry stratum (FVC≥ LLN and FEV1/FVC ≥LLN) 
for patients with R5-R20 ≤ 100% predicted (green) and R5-R20 > 100% predicted (red): ACQ-6 
(B), AQLQ(C) and exacerbations (D). Data are presented as median (Q1-Q3). 
Figure OS.3: Analysis of low and high points for the resistive difference index. Plots of the 
maximum index value ( ) are given, using i = 5, 8, 10, 12, 15, 18, and 20Hz. For each choice ∆𝑅𝑖𝑗
of low point, the high point varies from i+1 to 35Hz. As can be seen, the largest index values 
occur when i = 5Hz, and j = 20-25Hz, corresponding to markers such as R5-R20, and R5-R25. 
Figure OS.4: Comparison of R5-R20 response under skew-normally distributed 
constrictions. Responses are given for constriction of single Strahler orders (C, D), and of all the 
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small and central airways (E, F) for negatively skewed (A) and positively skewed (B) 
distributions. In all cases, R5-R20 is largest when constricting the small airways (Strahler orders 
1-6). 
Page 50 of 54 AJRCCM Articles in Press. Published on 18-May-2019 as 10.1164/rccm.201812-2322OC 
 Copyright © 2019 by the American Thoracic Society 
 Figure OS.1: Diagram of the integrated FOT modelling approach. Patient specific CT scan data (A) is used to 
create patient-based virtual airway structures (1) (to generations 6-10), with the remainder of the small 
conducting airways being generated algorithmically (2) (B). These structures then have patient-specific 
impedances calculated through an electrical circuit analogous model (C), which is connected to global 
models for tracheal and chest wall contributions, and cheek shunting (D). This allows for the effective 
simulation of resistance (E) and reactance (F) curves across the desired frequency range. 
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 Figure OS.2: Population stratification and clinical outcomes in patients with normal spirometry. (A) Dot plot 
presenting study population according to spirometric outcomes (B-D) Data presented for patients in the 
normal spirometry stratum (FVC≥ LLN and FEV1/FVC ≥LLN) for patients with R5-R20 ≤ 100% predicted 
(green) and R5-R20 > 100% predicted (red): ACQ-6 (B), AQLQ(C) and exacerbations (D). Data are 
presented as median (Q1-Q3). 
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 Figure OS.3: Analysis of low and high points for the resistive difference index. Plots of the maximum index 
value (∆Rij) are given, using i = 5, 8, 10, 12, 15, 18, and 20Hz. For each choice of low point, the high point 
varies from i+1 to 35Hz. As can be seen, the largest index values occur when i = 5Hz, and j = 20-25Hz, 
corresponding to markers such as R5-R20, and R5-R25. 
274x109mm (96 x 96 DPI) 
Page 53 of 54  AJRCCM Articles in Press. Published on 18-May-2019 as 10.1164/rccm.201812-2322OC 
 Copyright © 2019 by the American Thoracic Society 
 Figure OS.4: Comparison of R5-R20 response under skew-normally distributed constrictions. Responses are 
given for constriction of single Strahler orders (C, D), and of all the small and central airways (E, F) for 
negatively skewed (A) and positively skewed (B) distributions. In all cases, R5-R20 is largest when 
constricting the small airways (Strahler orders 1-6). 
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